Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide
Heike Hall*, Emma J. Williams* † , Stephen E. Moore*, Frank S. Walsh*, Alain Prochiantz ‡ and Patrick Doherty* Background A large number of growth factors stimulate cell proliferation and/or differentiation by binding to and activating membrane-spanning receptors that have intrinsic tyrosine kinase activity in their cytoplasmic domains [1] . Ligand binding induces receptor dimerization and auto-phosphorylation, creating high-affinity binding sites for downstream effector molecules. For example, phospholipase C ␥ (PLC␥) can bind through its SH2 domain to receptors that are activated by fibroblast growth factor (FGF), epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and neurotrophin-3 (NT-3), and this binding is required for phospholipid hydrolysis stimulated by these factors [1] [2] [3] [4] [5] [6] . Following ligand binding, the FGF receptor (FGFR) becomes phosphorylated on the tyrosine residue at position 766 ( 766 Tyr), creating a high-affinity binding site for PLC␥ [7] [8] [9] . The consequent phosphorylation and activation of PLC␥ is reflected in an increased hydrolysis of phospholipids that can be measured by the accumulation of inositol phosphates (IPs) [8, 9] .
Phosphorylated peptides that correspond to the highaffinity sites on the activated receptors are able to compete, in vitro, for PLC␥ binding to the receptors [1, 7, [10] [11] [12] [13] [14] . These results suggest that, provided they can be delivered into cells, peptides corresponding to the high-affinity PLC␥ binding sites from individual receptors might serve as specific inhibitors of phospholipid hydrolysis. A 16 amino-acid peptide corresponding to the third helix of the homeodomain of the Antennapedia protein can readily translocate across biological membranes [15] ; this translocation does not require energy and does not appear to be receptor-mediated. Following conjugation, the third helix peptide has been shown to be able to act as an internalization vector for other peptide sequences, and it has been used recently to deliver a pseudosubstrate peptide inhibitor of protein kinase C into
Results:
The peptide containing the FGFR high-affinity binding site for PLC␥ inhibited phospholipid hydrolysis stimulated by basic FGF with a maximal effect at 1 g ml - 1 . Phosphorylation of 766 Tyr was required for this effect. The phosphorylated peptide had no effect on phospholipid hydrolysis stimulated by platelet-derived growth factor, neurotrophin-3 and bradykinin. The phosphorylated peptide also inhibited neurite outgrowth stimulated by FGF, but had no effect on neurite outgrowth stimulated by agents that activate the FGFR signal transduction cascade downstream from the activation of PLC␥.
Conclusions:
Cell-permeable peptides can be designed that inhibit the function of receptor tyrosine kinases. In this context we have developed a peptide that prevents the FGFR from activating PLC␥, and have used this peptide to obtain the first direct evidence that activation of PLC␥ is required for the neurite outgrowth response stimulated by basic FGF.
neurons [16] . We have designed a peptide that contains the Antennapedia internalization sequence in tandem with a nine amino-acid peptide corresponding to the highaffinity PLC␥-binding site on the activated FGFR. Here, we report that, when phosphorylated on 766 Tyr, this peptide specifically inhibited the hydrolysis of phospholipids stimulated by basic FGF; in contrast, the unphosphorylated peptide had no effect on this response. The phosphorylated peptide also inhibited neurite outgrowth stimulated by FGF, providing the first direct evidence that PLC␥ activation is required for this response in primary neurons. These data provide direct evidence that the neurite outgrowth response to FGF requires activation of PLC␥, and highlight the potential for developing a novel family of peptide reagents to inhibit receptoreffector interactions in vivo.
Results
A peptide corresponding to the FGF receptor PLC␥-binding site inhibits IP accumulation.
The mechanism whereby FGF activates PLC␥ is shown schematically in Figure 1 . In the present study, we wanted to determine whether this response could be inhibited by a peptide containing the Antennapedia internalization sequence in tandem with a phosphorylated peptide corresponding to the FGFR high-affinity binding site for PLC␥ (called the 766 Tyr-P peptide; see Fig. 1 ). We therefore cultured small cerebellar granule cells from postnatal day 1 rats overnight before testing basic FGF for its ability to stimulate PLC␥ activity as measured by the accumulation of IPs (see Materials and methods for details). In an initial set of experiments, we established that an increase in IP accumulation could be detected within minutes of the addition of the growth factor (data not shown), and that at 60 minutes a maximal response was induced by FGF at 100 ng ml -1 (Fig. 2) . In parallel experiments, the test peptide was added to the cultures for 60 minutes prior to the addition of FGF as well as during the FGF treatment step. In control cultures (no FGF), the 766 Tyr-P peptide had no effect on the basal accumulation of IPs measured, even when present at up to 10 g ml -1 (the measured value being 97 ± 7 % of the control; mean ± SEM from four independent experiments). In the presence of FGF, a partial inhibition of the response was observed at 0.1 g ml -1 of the 766 Tyr-P peptide, with a total inhibition at 1 g ml -1 (Fig. 2) .
The inhibition of IP accumulation suggested that the 766 Tyr-P peptide had gained access to the cytoplasmic compartment. In order to confirm this, the peptide was biotinylated [17] and its uptake into cells monitored by confocal microscopy, as described previously [15, 16] . In agreement with previous studies, we found that the peptide had been taken up into the neurons and could be localized by confocal microscopy to the cytoplasm of both the cell body and the growth cone (Fig. 3) .
Phosphorylation of 766 Tyr in the FGFR is required for PLC␥ binding. In order to determine whether phosphorylation of the peptide was essential to inhibit IP accumulation, we repeated the experiments with an unphosphorylated peptide; no inhibition of the FGF response was observed when this peptide was used at up to 10 g ml -1 (Fig. 2) .
Specificity of the inhibitory peptide
In order to determine whether the 766 Tyr-P peptide specifically inhibited phospholipid hydrolysis stimulated by FGF, we screened a number of other growth factors, whose receptors are known to bind and activate PLC␥, for their effects on IP accumulation in cerebellar neurons. PDGF [18] , NT-3 [6, 19, 20] , NGF [21] and EGF [2, 3] were tested at 1, 10 and 100 ng ml -1 . After 60 minutes, only PDGF and NT-3 had stimulated IP accumulation (Fig. 4) , and these responses were not inhibited by a maximally active concentration of the 766 Tyr-P peptide (Fig. 4) . A schematic of the experimental paradigm. Following ligand binding the FGFR becomes phosphorylated on 766 Tyr and this creates a high affinity binding site for PLC␥. PLC␥ is in turn phosphorylated and activated by the receptor, and as a result it hydrolyzes membrane phospholipids. The products of this reaction are inositol phosphates (IPs) and diacylglycerol (DAG). We have made a cell-permeable peptide that corresponds to the FGFR high-affinity binding site for PLC␥ in tandem with a sequence from the Antennapedia protein that has previously been shown to act as an internalization vector. This peptide was tested for its ability to inhibit PLC␥ activation by basic FGF. The bradykinin receptor is coupled to another PLC isoform via a G-protein [22] . When cerebellar neurons were stimulated with 1 g ml -1 bradykinin, a significant increase in accumulation of IPs was observed, and this effect was also not inhibited by the 766 Tyr-P peptide (Fig.  4 ). These data demonstrate an element of specificity in the activity of the inhibitory peptide towards activation of the PLC␥ by the FGF receptor, relative to at least two other receptor tyrosine kinases.
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The 766 Tyr-P peptide inhibits neurite outgrowth stimulated by basic FGF
In cells that overexpress transfected FGFRs, activation of PLC␥ is not required for mitogenic responses stimulated by FGF [8, 9] . A large body of evidence suggests, however, that this step is both necessary and sufficient to account for the increase in neurite outgrowth from cerebellar granule cells stimulated by this factor [23] . Over a 16 hour culture period, a maximal increase in neurite outgrowth can be induced by 5-10 ng ml -1 FGF [23] . Here, we found that this response was partially inhibited by the 766 Tyr-P peptide at 0.1 g ml -1 , and fully inhibited at 1 g ml -1 ( Fig. 5 ). Again, it was essential that the peptide was phosphorylated on 766 Tyr for this effect (Fig. 5 ). An almost full inhibition of the FGF response could also be induced by simply pre-treating the neurons with the 766 Tyr-P peptide prior to plating on the substratum and the addition of FGF, providing further evidence that it is the peptide within the cell that inhibits the response (Fig. 6 ).
Diacylglycerol (DAG) is the other product of the hydrolysis of phospholipids by PLC␥, and neurite outgrowth stimulated by FGF can be blocked by a DAG lipase inhibitor which prevents the hydrolysis of DAG and the subsequent production of arachidonic acid [23] . FGF has been shown to stimulate a DAG-lipase-sensitive increase in the levels of arachidonic acid in cerebellar neurons [24] . Agents that increase arachidonic acid levels in neurons, or the addition of arachidonic acid itself, stimulate neurite outgrowth from cerebellar neurons by activating the FGFR signal transduction cascade downstream of the FGFR-PLC␥ interaction Stimulation of IP accumulation by basic FGF and inhibition by the 766 Tyr-P peptide. Cultures of cerebellar granule cells were established overnight before being washed and incubated for 60 min with control media or media containing 100 ng ml -1 basic FGF. In parallel experiments, the cultures were additionally treated with the phosphorylated 766 Tyr-P peptide ( 766 Y-P) at 0.1 g ml -1 or 1 g ml -1 , or with the corresponding unphosphorylated peptide ( 766 Y) at 10 g ml -1 . The results show the accumulation of IPs, expressed as a percentage of the control value, determined in the given number of independent experiments. Bars show the standard error of the mean (SEM). When tested at 10g ml -1 , the peptides did not on their own affect the basal IP accumulation (measured values being 97 ± 7 % of control for the phosphorylated peptide and 97 ± 12 % for the unphosphorylated peptide, both values mean ± SEM from four independent experiments). 
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Figure 3
Uptake of the 766 Tyr-P peptide into neurons.
Representative examples of cerebellar neurons were treated for 2 h with (a,b) the biotinylated 766 Tyr-P peptide or with (c) a control biotinylated peptide that does not get taken up into cells (see Materials and methods for details). The cultures were washed and permeabilized and the peptides detected with FITC-conjugated streptavidin. The micrographs show optical sections through the cell which demonstrate that the biotinylated 766 Tyr-P can be localized to the interior of the cell. In contrast, cells treated with the control peptide were negative. [23] . In order to determine whether the 766 Tyr-P peptide was acting at the expected step in this cascade, we tested its effect on the neurite outgrowth response stimulated by arachidonic acid. At 10 M, arachidonic acid stimulated neurite outgrowth in a manner that was indistinguishable from the response to FGF (Fig. 6) ; whereas the FGF response was almost fully inhibited by pre-treating neurons with the 766 Tyr-P peptide, the response to arachidonic acid was unaffected (Fig. 6) . These experiments establish that the peptide inhibits the neurite outgrowth response upstream from the generation of arachidonic acid in the FGFR signal transduction cascade, and show that the peptide has no toxic or non-specific effects on neurons. A similar neurite outgrowth response can also be induced by melittin, potassium depolarisation and cholera toxin [23] , and these responses were also not inhibited by the phosphorylated peptide (data not shown).
Discussion
The lack of specific inhibitors for many cellular interactions precludes direct tests of their involvement in biochemical and biological responses within living cells. PLC␥ is a case in point, and to our knowledge there are no available inhibitors of this key enzyme. In principle, peptides corresponding to sites that are involved in the binding of effectors to targets or substrates should be able to compete for the interaction, and in this way inhibit function. Such a strategy has been used to develop pseudosubstrate-based peptide inhibitors of enzymes such as protein kinase C [25] . The use of peptide inhibitors is obviously limited by the ability to deliver the peptide into cells, and also by the affinity of the peptide for its intended target. Although peptides can be delivered into cells by methods such as electroporation or microinjection, these methods are not optimal in that it is difficult to get
Figure 4
Stimulation of IP accumulation by a range of growth factors and the lack of effect of the 766 Tyr-P peptide. Cultures of cerebellar granule cells were treated with 100 ng ml -1 PDGF, 10 or 100 ng ml -1 NT-3, or 1 g ml -1 bradykinin, in the presence or absence of 1 g ml -1 766 Tyr-P peptide, as described for FGF in Fig. 2 
(4)
(4) the peptide into the entire cell population in a reproducible manner. There seems little doubt that the best peptide inhibitor would be one that would freely cross biological membranes.
In the present study, we wanted to develop a reagent that would inhibit the activation of PLC␥ by FGF. In order to do so, we took advantage of the fact that the activation of this enzyme requires that it first binds to a high-affinity site on the activated FGFR, and the observation that peptides corresponding to this site compete for receptor binding in vitro (see above). In order to deliver this peptide into cells we made a tandem peptide that also contained a 16 amino-acid sequence that will not only cross membranes [15] , but will also carry other peptides [16] and antisense oligonucleotides [26] into cells. We found that this peptide inhibited IP accumulation stimulated by FGF, with a maximal inhibition at around 1g ml -1 of the peptide. It was essential that 766 Tyr was phosphorylated in order for the peptide to inhibit the response, in accord with the fact that phosphorylation is required for the binding of PLC␥ to the FGFR [1, [7] [8] [9] . The lack of inhibition by the unphosphorylated peptide is unlikely to reflect a failure of this peptide to translocate across the cell membrane as it carries less charge than the phosphorylated peptide and would be expected to be more soluble in the lipid bilayer; the presence of this peptide in cells was also confirmed by microscopy (data not shown).
PLC␥ contains two SH2 domains, one at the carboxyl terminus and the other at the amino terminus. Binding studies with randomized peptides suggest that these domains display different sequence specificities [11] . The FGFR has only one site that binds PLC␥, and this site is Stimulation of neurite outgrowth by basic FGF and inhibition by the 766 Tyr-P peptide. Cerebellar neurons were cultured in media supplemented with 10 ng ml -1 FGF alone, or FGF plus the 766 Tyr-P peptide ( 766 Y-P) at 0.1 or 1g ml -1 , or the unphosphorylated peptide ( 766 Y) at 1 g ml -1 . After 16 h, the cultures were fixed and the mean length of the longest neurite determined as described previously [23] .
The results show the absolute increase in mean neurite length over the value measured in cultures maintained in control media (31 ± 3 m, mean ± SEM from 20 independent experiments) in the given number of experiments. Bars show the SEM. At 10 g ml -1 , the peptides had no effect on basal neurite outgrowth in control cultures, the measured value being 37 ± 2 m and 33 ± 2 m for the phosphorylated and unphosphorylated peptide, respectively (both values are mean ± SEM from three independent experiments). 
Figure 6
Effects of pre-treatment with the 766 Tyr-P peptide on neurite outgrowth stimulated by FGF and arachidonic acid (AA). Cerebellar neurons were pre-treated with control media (DMEM) or DMEM containing the 766 Tyr-P peptide at 100 g ml -1 for 60 min prior to plating out into the culture chambers. The neurons were then cultured for 16 h in media supplemented with 5 ng ml -1 FGF or 10 M AA. After 16 h, the cultures were fixed and the mean length of the longest neurite determined. The results show the absolute increase over the value measured for neurons grown in control media (40.3 ± 1.0 m, mean ± SEM from six independent experiments) in the given number of experiments. Bars show the SEM. Pre-treatment with the peptide had no effect on basal neurite outgrowth (38.6 ± 0.8 m; mean ± SEM from six independent experiments). almost identical to the optimal sequence for binding to the amino-terminal SH2 domain [11] . However, it has not been determined whether the FGFR binds PLC␥ via its amino-or carboxy-terminal SH2 domain, and it is not possible to say with certainty which domain the 766 Tyr-P peptide would be expected to bind to. Likewise, it is as yet unclear whether one or both of the SH2 domains on PLC␥ are used to interact with the other receptors that activate this enzyme. It is difficult to predict whether the peptide that corresponds to the high-affinity binding site on the FGF receptor might also be expected to competeout binding of PLC␥ to other activated receptor tyrosine kinases, and this is something that is probably best tested for each receptor. In this context, we found that at 1 g ml -1 the 766 Tyr-P peptide did not inhibit a PDGF response, nor did it inhibit an NT-3 response. In both cases, a large body of evidence suggests that PLC␥ is activated following binding to defined phosphotyrosine residues in the activated receptors (the PDGF receptor and the TrkB and/or TrkC receptor) [6, 11, 13, 19, 20] . These data raise the interesting possibility that peptides derived from individual receptor tyrosine kinases might be able to be developed as agents that will specifically inhibit the ability of that receptor to activate a downstream signalling cascade, although a considerable amount of work will be required to fully test this hypothesis.
Here, we have taken the sequence of a known high-affinity binding site for PLC␥, introduced it into cells, and found that it does indeed inhibit the activation of PLC␥ by the activated FGFR. In many instances, it has not yet been established which phosphotyrosine in a receptor actually represents the physiological binding site for PLC␥. The results of the present study suggest that this might easily be determined by testing the relative abilities of a panel of phosphorylated peptides, derived from candidate sequences of the receptor, for their ability to inhibit IP accumulation. It follows that this approach can also be adopted for studying the binding of other signalling components to a range of receptors. This will clearly complement the more conventional methods of site-directed mutagenesis that were used to identify the PLC␥-binding site on the FGFR [8, 9] .
The development of cell-permeable peptides that inhibit activation of an effector molecule allows one to test whether that effector molecule is required for functional responses in cells. FGF has a wide range of biological activities that include modulation of cell phenotype, stimulation of cell division and stimulation of axonal growth [23, [27] [28] [29] [30] . Based on the expression of mutated receptors that no longer bind PLC␥, it has been suggested that activation of PLC␥ is not required for mitogenic responses [8, 9] , or for neuronal differentiation of PC12 cells [31] . However, by the very nature of the experimental paradigm, these results apply only to a situation where receptor number is artificially high as a consequence of the overexpression of transfected FGFRs. Furthermore, in the case of PC12 cells, the neurite outgrowth assay used as an index of differentiation required a transcription-dependant change in the cell from an adrenal to neuronal phenotype [32] ; the results with PC12 cells might not be pertinent, therefore, to FGF-stimulated neurite outgrowth from differentiated neurons. Based on a series of pharmacological perturbations, it has been suggested that FGF stimulated neurite outgrowth from cerebellar granule cells can be fully accounted for by the activation of PLC␥ [23] . In the present study, we tested this by determining whether the 766 Tyr-P peptide could inhibit this response. It was found that the presence of the peptide in the media, or indeed pre-treatment of neurons with the peptide, inhibited the growth response. Inhibition was apparent over the same concentration range as that required to inhibit the IP accumulation, and again was shown to be absolutely dependent on the phosphorylation status of 766 Tyr in the peptide. The peptide did not inhibit the neurite-outgrowth response stimulated by arachidonic acid, which is a downstream component of the signalling cascade, confirming that it was acting at the right place in the pathway and demonstrating that it had no non-specific effects on cell viability or general neurite outgrowth. These data therefore support our previous conclusion that activation of PLC␥ is both necessary and sufficient to account for the FGF stimulation of neurite outgrowth from cerebellar granule cells.
Based on what we know about the FGFR signal transduction cascade (see above), the most parsimonious explanation from the IP accumulation data and the studies on neurite outgrowth is that the 766 Tyr-P peptide acts by inhibiting the association of PLC␥ with the activated FGFR; it will be important to confirm this conclusion, however, by immunoprecipitating the FGFR from control and activated neurons. Likewise, although there are no reports of other SH2 domain interactions with this region of the FGFR, if these were to exist it follows that the 766 Tyr-P peptide might also compete for their binding to the receptor. In this context, the wealth of additional evidence implicating activation of PLC␥ in the signal transduction cascade underlying the neurite-outgrowth response stimulated by FGF [23] , and the fact that the 766 Tyr-P peptide does not inhibit the arachidonic acid response (see above), suggests that it is extremely unlikely that the peptide is inhibiting neurite outgrowth by blocking an unknown SH2 domain interaction with the FGFR.
Conclusions
This study describes a peptide that inhibits the ability of FGF to stimulate phospholipid hydrolysis, in the absence of any effect on stimulation of the same response by three other growth factors. To our knowledge, this is the first time that such a highly specific reagent has been produced for use with living cells. Using this reagent, we have obtained direct evidence that neurite outgrowth stimulated by basic FGF requires activation of PLC␥. By taking advantage of the internalization properties of the third helix peptide of the Antennapedia protein, and the known identity of the binding sites on receptors for a range of adaptor or signal transducing molecules, this study suggests that a novel family of peptides can be designed for use as tools for studying the biological consequences of receptor activation.
Materials and methods
Production of synthetic peptides
Peptides were synthesized on a 431A Applied Biosystem peptide synthesiser using p-Hydromethylphenoxy methyl polystyrene (HMP) resin and standard Fmoc chemistry. Two peptides were used: RQIKIWFQNR-RMKWKK, which corresponds to the 16 amino-acid sequence of the third helix of the homeodomain of the Antennapedia protein (underlined); and, in tandem, a nine amino-acid sequence, SNQEYLDLS, which corresponds to the PLC␥ binding site on the FGF receptor (see text for details). A phosphorylated Fmoc tyrosine (Novabiochem) was used to make one of the peptides and this residue, shown in bold in the sequence, corresponds to 766 Tyr in the FGFR. This peptide is referred to as the 766 Tyr-P peptide. Peptides were analysed for purity by analytical high-pressure liquid chromatography, and in both instances single peaks were observed. The peptides were desalted on a Sephadex G10 column (Pharmacia) and lyophilized. The peptides were made as stock solutions at 20 mg ml -1 in dH 2 O and these stocks stored frozen at -20°C.
Peptide uptake into cells
The uptake of biotinylated peptides into cells was monitored as described previously [15, 16] . In brief, cultures of cerebellar neurons were established overnight on polylysine (PL) coated wells of an 8-chamber tissue culture slide [23] . The cultures were washed and media replaced with DMEM containing 10 g ml -1 of the 766 Tyr-P peptide biotinylated by standard methods [17] or a control biotinylated peptide from the third helix of the Antennapedia protein that does not get taken up into cells (see [15] for details). After 2 h, the cultures were washed three times with tissue culture media, and fixed and permeabilized with ethano:acetic acid (9:1 by volume) for 5 min at -20°C. Non-specific protein binding sites were blocked by incubating the cultures for 30 min with Tris-buffered saline (TBS) containing 10 % fetal calf serum (FCS) and 0.02 % Tween. The cultures were then incubated in the same buffer containing FITC-conjugated Streptavidin (from Amersham at 1:200 dilution). The cultures were washed a further three times in TBS before being mounted for viewing by confocal microscopy.
IP accumulation in cultures of cerebellar granule neurons
Cultures of small cerebellar neurons from postnatal day 1 rat pups were established as described previously [33] and IP accumulation determined using standard procedures [34] . Briefly, 500 000 single cells from the dissociated cerebellum were cultured in individual wells of a 6-well tissue culture plate (NUNC) that had been coated with PL at 0.1 % in dH 2 O. In order to label the membrane lipids, the cultures were grown for 16 h in DMEM supplemented with 10 % FCS in the presence of 1Ci [ 3 H]myo-inositol (Amersham), washed three times with DMEM and preincubated for 30 min in DMEM containing 20 mM LiCl (DMEM-LiCl). The cultures were then incubated for 60 min in DMEMLiCl and 10 g ml -1 heparin (from Sigma) or in the same media supplemented with 100 ng ml -1 basic FGF (from Amersham) in the presence and absence of the synthetic peptides as described in the text. At the end of the 60 min incubation, ice-cold TCA was added (10 %) and the IPs extracted for 30 min at 8°C. TCA extracts were collected and the dishes washed a further three times with 0.5 ml dH 2 O. After adjusting the pH to 7.4 with 1 M NaOH, the samples were applied to a 0.5 ml bed of AG-1-X8 resin (formate form from BioRad). The columns were washed with 6 ml dH 2 O, 1 ml 50 mM NaBO 4 /60 mM ammonium formate buffer followed by the elution of the total IP fraction with 1 ml of 1 M ammonium formate, 0.1 M formic acid. The eluted samples were carefully mixed with 4 ml scintillation fluid (Aquasol, Packard, UK) and left for at least 2 h before counting the radioactivity. Duplicate values were determined for each condition in individual experiments, and the mean of this value pooled for the given number of independent experiments.
Analysis of neurite outgrowth
In one set of experiments, dissociated cerebellar neurons from postnatal day 1 rat pups (see [23] for full details) were plated at a density of 10 000 cells per individual well of an 8-chamber tissue culture slide (Lab-TekR) that had been coated only with PL (see above). Cells were cultured in DMEM supplemented with 10 % FCS for 16 h in media further supplemented with FGF (10 ng ml -1 ) and/or synthetic peptides as indicated. In a second set of experiments, dissociated neurons obtained from postnatal day 2-4 rat pups were resuspended in DMEM in the presence and absence of the 766 Tyr-P peptide at 100 g ml -1 . After 60 min, the peptide was removed from the media by washing the cells three times with DMEM. The neurons were then plated at a density of 6 000 cells per individual well of an 8-chamber tissue culture slide that had been coated with PL followed by laminin [23] . The cultures were grown for 16 h in DMEM/SATO medium supplemented with 2 % FCS. Both sets of cultures were fixed and immunostained for GAP-43 as described previously [23] . The length of the longest neurite on immunopositive cells was determined for approximately 150-200 neurons sampled from replicate cultures in each individual experiment.
